T1 직장암의 치료방법에 따른 종양학적 결과
Long-term Oncological Outcomes of T1 Rectal Cancer according to the Therapeutic Modalities
최평화, 유창식, 정상훈, 김대동, 홍동현, 김희철, 김진천,
소속 상세정보
최평화 ( Choi Pyong-Wha )
울산대학교 의과대학 외과학교실
유창식 ( Yu Chang-Sik )
울산대학교 의과대학 외과학교실
정상훈 ( Jung Sang-Hun )
울산대학교 의과대학 외과학교실
김대동 ( Kim Dae-Dong )
울산대학교 의과대학 외과학교실
홍동현 ( Hong Dong-Hyun )
울산대학교 의과대학 외과학교실
김희철 ( Kim Hee-Cheol )
울산대학교 의과대학 외과학교실
김진천 ( Kim Jin-Cheon )
울산대학교 의과대학 외과학교실
KMID : 0356720060220050330
Abstract
Purpose: Recent studies have showed a 7∼15% lymph node metastasis rate in T1 rectal cancer. Surgical options for T1 rectal cancer are radical resections, local excisions, and local excisions with adjuvant radiotherapy. Outcomes according to the type of surgery are variable. The present study was performed to assess outcomes of T1 rectal cancer according to therapeutic modalities and to provide guidelines for appropriate treatment of T1 rectal cancer.
Methods: A retrospective study of 117 patients with T1 rectal cancer who underwent surgery between June 1989 and December 2002 at Asan Medical Center was conducted. Radical resections, local excisions, and local excisions with adjuvant radiotherapy were performed as therapeutic modalities. Adjuvant radiotherapy after local excision was performed in patients with sm2 or sm3 cancers, lympho- vascular invasion (+), poorly differentiated cancer, and resection margin (+) or because of a patient’s refusal to undergo a radical resection.
Results: Twenty-five (21.3%) patients were treated by local excision, 14 (12.0%) by adjuvant radiotherapy after local excision, and 78 (66.7%) by radical resection. The distance from the anal verge was significantly longer in the radical resection group than in the local excision group (7.8±3.4 vs. 4.9±2.1 cm; P＜0.001). There was no significant difference by age, sex, or pathologic findings between the three groups. There was one local recurrence in the local excision group, one distant metastasis in the local excision with adjuvant radiotherapy group, and two distant metastases in the radical resection group. The 5-year cancer-specific survival and disease-free survival rates were as follows; local excision group, 94.1 and 95.8%, respectively; local excision with adjuvant radiotherapy group, 100 and 92.8%, respectively; radical resection group, 98.3 and 98.6%, respectively. There were no significant differences in survival between the groups.
Conclusions: Oncological outcomes of T1 rectal cancer patients were comparable among the surgical options. Adjuvant radiotherapy is recommended after local excision in patients with risk factors, such as sm2 or sm3 cancer, poorly differentiated cancer, and positive lympho-vascular invasion. J Korean Soc Coloproctol 2006;22:330-336
키워드
T1 직장암;치료방법;보조방사선 치료
T1 rectal cancer;Therapeutic modality;Adjuvant radiotherapy
원문 및 링크아웃 정보
등재저널 정보